Design, synthesis and biological evaluation of γ-lactam hydroxamate based TACE inhibitors

被引：8

作者：

Argade, Anil ^{[1
,2
]}

Bahekar, Rajesh ^{[1
]}

Desai, Jigar ^{[1
]}

Thombare, Pravin ^{[1
]}

Shah, Kiran ^{[1
]}

Gite, Sanjay ^{[1
]}

Sunder, Rajesh ^{[1
]}

Ranvir, Ramchandra ^{[1
]}

Bandyopadhyay, Debdutta ^{[1
]}

Chakrabarti, Ganes ^{[1
]}

Joharapurkar, Amit ^{[1
]}

Mahapatra, Jogeswar ^{[1
]}

Chatterjee, Abhijit ^{[1
]}

Patel, Harilal ^{[1
]}

Shaikh, Mubeen ^{[1
]}

Sairam, Kalapatapu V. V. M. ^{[1
]}

Jain, Mukul ^{[1
]}

Patel, Pankaj ^{[1
]}

机构：

[1] Zydus Res Ctr, Ahmadabad 382210, Gujarat, India

[2] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Chem, Vadodara 390002, Gujarat, India

来源：

MEDCHEMCOMM | 2011年 / 2卷 / 10期

关键词：

ALPHA CONVERTING-ENZYME; NECROSIS-FACTOR-ALPHA; SELECTIVE INHIBITORS; DISCOVERY; POTENT; METALLOPROTEINASE; DISINTEGRIN; ACIDS;

D O I：

10.1039/c0md00261e

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A new series of gamma-lactam hydroxamate based TACE inhibitors was designed mainly by introducing various substitutions at the 2nd position of the quinoline nucleus to achieve high potency and good selectivity towards TACE over matrix metalloproteases (MMPs) and ADAM-10. In ex vivo TNF-alpha inhibitory activity assays, compounds 11o and 11p were identified as the most potent compounds. The in vitro TACE inhibitory activity, selectivity over MMPs and ADAM-10 and the in vivo TNF-alpha inhibitory activities of compounds 11o and 11p were assessed and lead compound 11p was identified. Preliminary toxicity and pharmacokinetic (PK) studies were conducted for compound 11p and it showed an improved PK and clean toxicological profile compared to standard compound 1. Altogether, these results demonstrated the discovery of highly potent and selective gamma-lactam hydroxamate based TACE inhibitors which show potential for the safe and effective treatment of inflammatory diseases.

引用

页码：966 / 972

页数：7

共 50 条

[21] Synthesis and activity of quinolinylmethyl P1′ α-sulfone piperidine hydroxamate inhibitors of TACE
Zhang, Chunchun
Lovering, Frank
Behnke, Mark
Zask, Arie
Sandanayaka, Vincent
Sun, Linhong
Zhu, Yi
Xu, Weixin
Zhang, Yuhua
Levin, Jeremy I.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) : 3445 - 3448
[22] Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen
Nagarajan, M
Xiao, XS
Antony, S
Kohlhagen, G
Pommier, Y
Cushman, M
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (26) : 5712 - 5724
[23] Synthesis, preliminary biological evaluation and molecular modeling of some new heterocyclic inhibitors of TACE
Sengupta, Prabal
Puri, Chetan S.
Chokshi, Hemant A.
Sheth, Chetana K.
Midha, Ajay S.
Chitturi, Trinadha Rao
Thennati, Rajamannar
Murumkar, Prashant R.
Yadav, Mange Ram
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (11) : 5549 - 5555
[24] Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors
Kumar, G. D. Kishore
Chavarria, Gustavo E.
Charlton-Sevcik, Amanda K.
Arispe, Wara M.
MacDonough, Matthew T.
Strecker, Tracy E.
Chen, Shen-En
Siim, Bronwyn G.
Chaplin, David J.
Trawick, Mary Lynn
Pinney, Kevin G.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (04) : 1415 - 1419
[25] Design, Synthesis and Biological Evaluation of Aromatase Inhibitors Based on Sulfonates and Sulfonamides of Resveratrol
Fantacuzzi, Marialuigia
Gallorini, Marialucia
Gambacorta, Nicola
Ammazzalorso, Alessandra
Aturki, Zeineb
Balaha, Marwa
Carradori, Simone
Giampietro, Letizia
Maccallini, Cristina
Cataldi, Amelia
Nicolotti, Orazio
Amoroso, Rosa
De Filippis, Barbara
PHARMACEUTICALS, 2021, 14 (10)
[26] Discovery of novel spirocyclopropyl hydroxamate and carboxylate compounds as TACE inhibitors
Guo, Zhuyan
Orth, Peter
Wong, Shing-Chun
Lavey, Brian J.
Shih, Neng-Yang
Niu, Xiaoda
Lundell, Daniel J.
Madison, Vincent
Kozlowski, Joseph A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (01) : 54 - 57
[27] Design, synthesis and biological evaluation of peptidomimetic FXIa inhibitors
Lin, J
Deng, HF
Jin, L
Pandey, P
Rynkiewicz, M
Bibbins, F
Cantin, S
Quinn, J
Magee, S
Gorga, J
Celatka, C
Nagafuji, P
Bannister, T
Meyers, HV
Babine, R
Hayward, N
Abdel-Meguid, SS
Strickler, J
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U153 - U153
[28] Design, synthesis and biological evaluation of peptidomimetic inhibitors of thrombin
Ogbu, CO
Boatman, PD
Eguchi, M
Cao, GL
Nakanishi, H
Kahn, M
Tulinsky, A
Padmanabhan, K
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 60 - MEDI
[29] Design, synthesis and biological evaluation of potent FAAH inhibitors
Tuo, Wei
Leleu-Chavain, Natascha
Barczyk, Amelie
Renault, Nicolas
Lemaire, Lucas
Chavatte, Philippe
Millet, Regis
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (11) : 2701 - 2705
[30] Design, synthesis and biological evaluation of novel KSP inhibitors
Ruan Xiu-Qin
You Qi-Dong
Yang Lei
Wu Wu-Tong
ACTA CHIMICA SINICA, 2008, 66 (14) : 1731 - 1734

← 1 2 3 4 5 →